NCT06361836View on ClinicalTrials.gov

Study of Single Doses of SBT777101 in Subjects With Hidradenitis Suppurativa

PHASE1RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 9, 2024

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions
Hidradenitis Suppurativa
Interventions
BIOLOGICAL

SBT777101

Experimental treatment

Trial Locations (6)

10032

RECRUITING

Columbia University Irving Medical Center, New York

27708

RECRUITING

Duke University, Durham

55455

RECRUITING

University of Minnesota, Minneapolis

63110

RECRUITING

SLUCare Academic Pavillion, St Louis

77030

RECRUITING

The University of Texas MD Anderson Cancer Center, Houston

02115

RECRUITING

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Sonoma Biotherapeutics, Inc.

INDUSTRY